Tobias Friedrich

Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial

Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Andreas G. Niethammer et al. · OncoImmunology · 2015 · 75 citations · Full text

Medicine, Immunology, Oncology +17

A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer

Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Thomas Schmidt et al. · OncoImmunology · 2017 · 73 citations · Full text

Medicine, Immunology, Oncology +17

Efficient key pathway mining: combining networks and OMICS data

Nicolás Alcaraz, Tobias Friedrich, Timo Kötzing et al. · Integrative Biology · 2012 · 65 citations

Life Sciences, Bioinformatics, Biology +17

JAZF1, A Novel p400/TIP60/NuA4 Complex Member, Regulates H2A.Z Acetylation at Regulatory Regions

Tara Procida, Tobias Friedrich, Antonia P. M. Jack et al. · International Journal of Molecular Sciences · 2021 · 38 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Notch-dependent and -independent functions of transcription factor RBPJ

Tobias Friedrich, Francesca Ferrante, Léo Pioger et al. · Nucleic Acids Research · 2022 · 36 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14